Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2025 07:30 ET | Source: MicrobiotiX

MicrobiotiX and West Africa Centre for Innovative Research and Care in Ghana Sign MoU to Advance Clinical Development of Bacteriophage Therapeutics and Combat AMR·MDR in Africa

MicrobiotiX and KATH sign MoU to advance clinical bacteriophage therapies against AMR·MDR and expand treatment options for patients in Africa.
November 20, 2025 06:00 ET | Source: bioMérieux

4th Edition of bioMérieux Canada Symposium: Over 300 Canadian Health Experts Unite in Toronto to Tackle the Growing Threat of Antimicrobial Resistance

“Antimicrobial resistance is advancing silently, but its consequences are all too real"
October 27, 2025 07:30 ET | Source: MicrobiotiX

MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101

MicrobiotiX gains IND approval to initiate clinical trials for its pneumonia therapy designed to combat antibiotic-resistant superbugs.
September 17, 2025 14:43 ET | Source: Forte Medical Limited

Are Women on the Frontline of Antimicrobial Resistance?

Are women on the AMR Frontline? Results of a national patient survey of women's experiences around Urinary Tract Infection and antibiotic prescribing
September 15, 2025 08:00 ET | Source: FactSet Research Systems Inc.

FactSet Adds J.P. Morgan, Barclays to Aftermarket Research Offering

NORWALK, Conn., Sept. 15, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS | NASDAQ:FDS), a global financial digital platform and enterprise solutions provider, today announced that J.P. Morgan and...
September 03, 2025 07:30 ET | Source: MicrobiotiX

MicrobiotiX Finalizes KRW 20 Billion Series B, Securing Korea's First Bacteriophage Clinical Trial

MicrobiotiX raises KRW 20B Series B and wins grant to launch Korea’s first phage therapy trial, advancing fight against superbugs.
August 07, 2025 03:00 ET | Source: SNIPR BIOME

SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance

SNIPR Biome today announced the close of a EUR 35 million Series B financing round addressing antimicrobial resistance and infectious disease.
August 06, 2025 02:00 ET | Source: Forte Medical Limited

Forte Medical National Survey Announcement

UK MedTech company launches patient experience survey around overlooked & unreliable Urinary Tract Infection and prenatal screening diagnostics.
July 16, 2025 09:00 ET | Source: Vivid Dx

Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member

OXFORD, United Kingdom, July 16, 2025 (GLOBE NEWSWIRE) -- Vivid Dx, a precision diagnostics company transforming pathogen detection and antimicrobial resistance (AMR) testing, today announced the...
June 25, 2025 08:45 ET | Source: Itron, Inc.

Itron Celebrates Shipment of 2 Millionth Cyble™ 5 Communication Module

Itron shipped more than 2 million of its Cyble 5 multi-connectivity communication modules and French water utility, Metz Eurométropole, is the recipient.